Hipertensión Arterial en el Adulto Mayor: una mirada actual. Primera parte (página 2)

32. Murgo WW, Westerhof N, Giolma JP, Altobelli
SA. Aortic input impedance in normal men, relationship to
pressure wave forms. Circulation. 2008;62:105-16.

33. Nichols WW, Rourke O', Avolio AP, Yaginuma
T, Murgo JP, Pepine CJ. Effects of age on
ventricular-vascular coupling. Am Journal Cardiologic.
2008;55:1179-84.

34. Latham RD, Westerhof N, Sipkema P, Rubal
BJ, Reuderink P, Murgo JP. Regional wave travel and
reflections along the human aorta: a study with six
simultaneous micromanometric pressures. Circulation.
2005;72:1257-69.

35. Chen CH, Ting CT, Nussbacher A, Nevo E,
Kass DA, Pak P, et al. Validation of carotid artery tonometry
as a means of estimating augmentation index of ascending
aortic pressure. Hypertension. 1996;27:168-75.

36. Mayet J, Hughes A. Cardiac and vascular
pathophysiology in hypertension. Heart.
2008:89;1104-9.

37. Rouleau J, Juneau C, Stephens H, Shenasa H,
Parmley WW, Brutsaert DL. Mechanical properties of papillary
muscle in cardiac failure: importance of pathogenesis and of
ventricle of origin. Journal Mol Cell Cardiology.
1989:21:817-28.

38. Swynghedauw B. Molecular mechanisms of
myocardial remodelling. Physiology Rev.
1999;79:215-62.

39.  Hansen-Smith F, Greene AS, Cowley AW,
Lombard JH. Structural changes during microvascular
rarefaction in chronic hypertension. Hipertensión.
2009;15:922-8.

40. Jono S, McKee MD, Murry CE, Shioi A,
Nishizawa Y, Mori K, et al. Phospate regulation of vascular
smooth muscle cell calcification. Circ Res.
2007;27:10-17.

41. Safar ME, London GM, Plante GE. Arterial
stiffness and kidney function. Hypertension.
2007;43:163-8.

42. Veigh GE, Bratteli CW, Morgan DJ, Alinder
CM Glasser SP, Finkeltein SM, et al. Age-related
abnormalities in arterial compliance identified by pressure
pulse contour analysis. Aging and arterial compliance.
Hypertension. 1999;33:1392-8.

43. Weber KT. Aldosterone in congestive heart
failure. New England Journal Medicine.
2007;345:1689-97.

44. Lacolley P, Labat C, Pujol A, Delcayre C,
Benetos A, Safar M. Increased carotid wall elastic modulus
and fibronectin in aldosterone-salt-treated rats.
Circulation. 2007;106:2848-2853.

45. Goodman WG, Goldin J, Kuizon BD, Yoon C,
Gales B, Sider D, et al Coronary artery calcification in
young adults with end stage renal disease who are undergoing
dialysis. New England Journal Medical.
2007;342:1478-1483.

46. Yerkey MW, Kernis SJ, Franklin BA, Sandberg
KR, McCullough PA. Renal dysfunction and acceleration of
coronary disease. Herat. 2008;90:961-966.

47. Mikhail N, Golub MS, Tuc ML. Obesity and
hypertensión. Program Cardiovasc Disease.
2009;42:39-58.

48. Sorof JM, Daniels S. Obesity hypertension
in children: a problem of epidemic proportions. Hypertension.
2007;441-447.

49. Whincup PH, Gilg JA, Donald AE. Arterial
distensibility in adolescents: the influence of adiposity,
the metabolic syndrome, and classic risk factors.
Circulation. 2007;112:1798-1797.

50. Wildman RP, Mackey RH, Boston A. Measures
of obesity are associated with vascular stiffness in young
and older adults. Hypertension. 2008;42:468-473.

51. Woo KS, Chook P, Yu CW. Effects of diet and
exercise on obesity related vascular dysfunction in children.
Circulation. 2004;109:1981-1986.

52. Tounian P, Aggoun Y, Dubern B. Presence of
increased stiffness of the common carotid artery and
endothelial dysfunction in severly obese children:a
prospective study. Lancet. 2007;358:1400-1404.

53. Woo KS, Chook P, Yu CW. Overweight in
children is associated with arterial endothelial dysfunction
and intima-media thickening. Int Journal Obesity Relat Metab
Disorder. 2008;28:852-7.

54. Reaven GM, Lithell H, Landsberg L.
Hypertension and associated metabolic abnormalities-the role
of insulin resistance and the sympathoadrenal system. New
England Journal Medical. 1996;334:374-81.

55. Safar ME, Asmar R, Benetos A, Levy BI,
London GM. Sodium, large arteries, and diuretic compounds in
hypertension. Am Journal Medical Sci. 1994;307 suppl
1:S3-8.

56. Vardan S, Mookherjee S, Warner R, Smulyan
H. Systolic hypertensión. Direct and indirect
measurements. Archiv International Medical.
1983:143:935-8.

57. González GA, García BD, Gamio
CF, Hernández CA. Effects of propranolol and atenolol
on plasma renin activity and systolic time intervals in
borderline hipertension. Cordova Vasa.
2002;24:422-8.

58. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC,
Maugham WL, et al. Estimation of central aortic pressure
waveform by mathematical transformation of radial tonometry
pressure. Validation of generalized transfer function.
Circulation. 2007;95:1827-36.

59. Hoeks APG, Brands PJ, Smeets GAM, Reneman
RS. Assessment of the distensibility of superficial arteries.
Ultrasound Medical Biology. 1990;16:121-8.

60. Tardy YJ, Meister JJ, Perret F, Brunner HR,
Ardite M. Noninvasive estimate of the mechanical properties
of peripheral arteries from ultrasonic and
photoplethysmographyc measurements. Clin Phys Physiol Meas.
2007;3:360-367.

61. Chen CH, Ting CT, Nussbacher, Nevo E, Kass
DA, Pak P, et al. Validation of carotid artery tonometry as a
means of estimating augmentation index in ascending aortic
pressure. Hypertension. 1996;27:168-175.

62. Khoshdel AR, Carney SL. Increased pulse
wave velocity is not associated with elevated augmentation
index in patients with diabetes. Journal Hypertens.
2009;23:669-670.

63. Fantin F, Mattocks A, Bulpitt CJ, Banya W,
Rajkumar C. Is augmentation index a good measure of vascular
stiffness in the elderly?. Age Aging.
2007;36:43-48.

64. Cheng LT, Tang LJ, Cheng L, Huang HY, Wang
T. Limitation of the augmentation index for evaluating
arterial stiffness. Hypertens Res.
2007;30:713-722.

65. Iemitsu M, Maeda S, Otsuki T, Sugawara J,
Kuno S, Ajisaka R, et al. Arterial stiffness, physical
activity, and atrial natriuretic peptide gene polymorphisim
in older subjects. Hypertens Res. 2008;31:767-74.

66. Gates PE, Tanaka H, Hiatt WR, Seals DR.
Dietary sodium restriction rapidly improves large elastic
artery compliance in older adults with systolic hypertension.
Hypertension. 2008;44:35-41.

67. Domanski MJ, Mitchell GF, Norman JE, Exner
DV, Pitt B, Pfeffer MA. Independent prognostic information
provided by sphygmomanometrically determined pulse pressure
and mean arterial pressure in patients with left ventricular
dysfunction. Journal Am Coll Cardiology.
2009;33:951-8.

68. Vokó Z, Bats ML, Hofman A. J-shaped
relation between blood pressure and stroke in treated
hypertensives. Hypertension. 2009;34:1181-5.

69. Pinto E. Blood pressure and aging. Postgrad
Medical Journal. 2007;83:109-14.

70. Gueyffer F, Bulpitt C, Boissel JP, Schron
E, Ekbom T, Fagard R, et al. Antihypertensive drugs in very
old people: a subgroup meta-analysis of randomised controlled
trials. INDANA Group. Lancet. 2009;353:793-6.

71. Beckett NS, Peters R, Fletcher AE, Staessen
JA, Liu L, Dumitrascu D, et al. Treatment of
hypertensión in patients 80 years of age or older New
England Journal Medical. 2008;358: NEJMoa0801369.

72. Kerins DM, Robertson RM, Robertson D. Drugs
used for the treatment of myocardial ischemia. En: Goodman's
Gilman's. The Pharmacological Basis of Therapeutics. 10ma.
edición. New York: McGraw-Hill;
2007:843-870.

73. Troncale JA. The aging process. Physiologic
changes and pharmacologic implications. Postgrad Medical.
1996;99:111-4.

74. Steiner JF. Pharmacotherapy problems in the
elderly. Journal Am Pharmacology Association.
2007;36:431-7.

75. García Barreto D, Toruncha A. Los
inhibidores de la enzima conversora de angiotensina. Revista
Cubana Cardiología Circuito Cardiovascular.
2007:11;29-47.

76. Antagonistas de la angiotensina II. Revista
Cubana Cardiología Circuito Cardiovascular.
2009;13:158-66.

77. García BD. Efecto de los
diuréticos en el tratamiento de la hipertensión
arterial. Revista Cubana Cardiología Circuito
Cardiovascular. 1990;4:69-76.

78. Mahmud A, Feely J. Aldosterone antagonism
reduces arterial stiffness; relationship to aldosterone renin
ratio. Journal Hum Hypertens. 2008;17:S19-S20.